A treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults: A one-year private practice study with long-acting stimulants, fluoxetine, and bupropion

Substance Abuse

Volumn 20, Issue 1, 1999, Pages 59-71

  Castaneda, Ricardo ^a   Sussman, Norman ^b   Levy, Robert ^b   Trujillo, Manuel ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Attention deficit hyperactivity disorder; Cocaine dependence; Treatment

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; FLUOXETINE; METHAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; PEMOLINE MAGNESIUM;

ADULT; ALGORITHM; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COCAINE DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; OUTPATIENT; PSYCHOLOGICAL ASPECT; REMISSION; TREATMENT PLANNING;

EID: 0033059305     PISSN: 08897077     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021300907111     Document Type: Article

References (23)

1. Castaneda R, Galanter M, Franco H: Self medication among addicts with primary psychiatric disorders. Compr Psychiatry 1989; 30:80-83
2. Castaneda R, Galanter M, Lifshutz H, Franco H: Effects of drugs of abuse on psychiatric symptoms among hospitalized schizophrenics. AM J Drug Alcohol Abuse 1991; 17(3):313-320
3. Castaneda R, Lifshutz H , Galanter M, Franco H: An empirical assessment of the self-medication hypothesis. Compr Psychiatry 1994; 2:180-184
4. Weiss RD, Pope HG, Mirin SM: Treatment of cocaine abuse and attention deficit disorder, residual type with magnesium pemoline. Drug Alcohol Depend 1985; 15:69-72
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press; 1994
6. Carroll KM, Rounsaville BJ: History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34; 2:75-81, 1993
7. Wilens TM, Biederman J, Spencer TG, Frances RJR: Comorbidity of attention-deficit hyperactivity disorder and psychoactive substance use disorders. Hosp Commun Psychiatry 45; 5:421-435, 1994
8. Wood RD, Reimherr FW, Wender PH, Johnson PE: Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 1976; 33:1453-1460
9. Wender PH, Remitter FW, Wood DR: Attention deficit disorder ("minimal brain dysfunction") in adults: A replication study of diagnosis and treatment. Arch Gen Psychiatry 1981; 38:449-454
10. Mattes JA, Boswell L, Oliver H: Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984; 41:1059-1063
11. Wender PH, Reimherr FW, Wood DR, Ward M: A controlled study of methylphenidate in the treatment of attention deficit disorder residual type in adults. Am J Psychiatry 1985; 142:547-552
12. Caresia L, Pugnetti L, Besana R, Barteselli F, Guareschi Casullo A, Musetti L, Scarone S: EEG and clinical findings during periods of treatment in children and adults with attention deficit disorder; an 8 week open trial. Neuropsychobiology 1984; 11:158-167
13. Gualtieri CT, Ondrusek MG, Finley C: Attention deficit disorder in adults. Clin Neuropharmacol 1985; 8:343-356
14. Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon JS, Lapey K: A double blind comparison of methylphenidate and placebo in adults with adult deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52;350-353
15. Barrickman L, Noyes R, Kuperman S: Treatment of attention deficit hyperactivity disorder with fluoxetine: A preliminary trial. J Acad Child Adolesc Psychiatry 1991; 30:762-767
16. Wender POH, Reimherr RW: Bupropion treatment of attention deficit disorder ("minimal brain dysfunction") in adults. J Acad Child Adolesc Psychiatry 1986; 147:1018-1023
17. Wender PH: Attention-Deficit Hyperactivity Disorder in Adults. New York: Oxford University Press; 1995
18. Khantzian EJ, Gawin FI, Kleber HD, Riordan CE: Methylphenidate treatment of cocaine dependence: a preliminary report. J Substance Abuse Treat 1984; 1:107-112
19. Callahan PM, Appel JB, Cunninham KA: Dopamine D1 and D2 medication of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 1991; 103:50-55
20. Wilens TM, Spencer TJ, Biederman J: Role of medication in the treatment of adult attention deficit disorder. In: Nadeau KG, ed. Attention Deficit Hyperactivity Through the Lifespan. New York: Brunner/Mazel; 1994
21. Zametkin AJ, Rapoport JL: Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Acad Child Adolesc Psychiatry 1987; 26:676-686
22. Hunt RD: Nosology, neurobiology, and clinical patterns of AHDH in adults. Psychiatr Annu 1997; 27:8:572-581
23. Grabowski J, Roache JD, Schmitz JM: Replacement medication for cocaine dependence. J Clin Psychopharmacol 1997; 17:485-488